Viral Hepatitis and Hepatocellular Carcinoma.

Viral Hepatitis and Hepatocellular Carcinoma.
复制标题

病毒性肝炎和肝细胞癌。

DOI:
10.1053/j.gastro.2018.12.016
复制
发表时间:
2019
期刊:
影响因子:
29.4
通讯作者:
Terrault,Norah
Terrault,Norah
中科院分区:
医学1区
文献类型:
--
作者:
Liang,TJake;Terrault,Norah

文献摘要

相似文献

几十年来,病毒性肝炎一直是一个重要的公共卫生威胁。肝炎病毒感染全世界数百万人。慢性感染B型肝炎病毒(HBV)、HCV或HDV与肝硬化和肝癌相关,并且是人类中最知名的癌症感染原因之一。病毒性肝炎相关肝癌是全球死亡的主要原因,但已经有许多重要的科学发现和医学进步。因此,我们专门为病毒性肝炎和肝细胞癌的胃肠病学特刊。这期特刊总结了最先进的科学,突出了知识差距和未满足的需求,并讨论了剩余的挑战和未来的方向。尽管不可能涵盖所有主题,但我们希望这一问题将成为医学和科学界的宝贵资源和蓝图,因为我们继续与这一全球祸害作斗争。我们汇集了最重要的权威,他们是关于公共卫生问题、疾病进展、诊断、分子病毒学、免疫学、基因组学和遗传学、肿瘤发生、预防、以及病毒性肝炎和肝细胞癌治疗的发展。我们感谢所有作者的努力和专业知识,他们的集体贡献使这一问题的特殊性。我们特别高兴的是,Harvey Alter(HBV的共同发现者)和弗朗西斯奇萨里(一位对该领域做出巨大贡献的杰出科学家)撰写了一篇优雅而有先见之明的介绍性文章,为这个特殊问题和该领域的进展提供了独特的专家概述。
For many decades, viral hepatitis has been an important public health threat. Hepatitis viruses infect millions of people worldwide. Chronic infections with hepatitis B virus (HBV), HCV, or HDV are associated with cirrhosis and liver cancer, and are among the bestknown infectious causes of cancer in humans. Viral hepatitis-associated liver cancer is a leading cause of death worldwide, but there have been many important scientific discoveries and medical advances. We have therefore dedicated a special Issue of Gastroenterology to viral hepatitis and hepatocellular carcinoma. This special issue summarizes state of the art science, highlights knowledge gaps and unmet needs, and discusses remaining challenges and future directions. Although it is impossible to cover all topics, we hope this issue will be a valuable resource and blueprint for the medical and scientific community as we continue our progress against this global scourge.We have assembled the foremost authorities as authors of articles on public health issues, disease progression, diagnostics, molecular virology, immunology, genomics and genetics, oncogenesis, prevention, and development of treatments for viral hepatitis and hepatocellular carcinoma. We are thankful for all the authors’ efforts and expertise—their collective contributions make this issue special. We were particularly delighted that Harvey Alter (the co-discoverer of HBV) and Francis Chisari (a towering scientist with immense contributions to the field) wrote an elegant and prescient introductory Perspective article that provides a unique, expert overview of this special issue and the field’s progress.